Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke.

Nonparametric Statistics for the Behavioral Sciences

1958 • 36,277 citations

Classification and natural history of clinically identifiable subtypes of cerebral infarction

1991 • 3,237 citations

Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.

1997 • 1,510 citations

The matrix‐degrading metalloproteinases

1992 • 1,383 citations

SV40-transformed Human Lung Fibroblasts Secrete a 92-kDa Type IV Collagenase Which Is Identical to That Secreted by Normal Human Macrophages

1989 • 1,122 citations

H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.

1988 • 1,050 citations

Inflammation and glial responses in ischemic brain lesions

1998 • 788 citations

Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke.

1992 • 617 citations

Reverse ELISPOT assay for clonal analysis of cytokine production I. Enumeration of gamma-interferon-secreting cells

1988 • 496 citations

Early Intrathecal Production of Interleukin-6 Predicts the Size of Brain Lesion in Stroke

1995 • 375 citations

Microvascular Basal Lamina Antigens Disappear During Cerebral Ischemia and Reperfusion

1995 • 369 citations

Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease

1994 • 332 citations

Advances in the Vascular Pathophysiology of Ischemic Stroke

2000 • 320 citations

Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia

1997 • 319 citations

Hemorrhagic Transformation and Microvascular Integrity during Focal Cerebral Ischemia/Reperfusion

1996 • 291 citations

Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview

1997 • 281 citations

Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA)

1991 • 278 citations

Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke

1997 • 265 citations

Structure and expression of the human gene for the matrix metalloproteinase matrilysin.

1994 • 243 citations

Interleukin‐6 and interleukin‐1 receptor antagonist in acute stroke

1995 • 235 citations

Potential mechanisms of interleukin-1 involvement in cerebral ischaemia

1999 • 232 citations

Extracellular matrix degradation by metalloproteinases and central nervous system diseases

1999 • 230 citations

Intrathecal release of pro- and anti-inflammatory cytokines during stroke

1997 • 229 citations

The complete primary structure of human matrix metalloproteinase-3. Identity with stromelysin.

1988 • 227 citations

The Role of Cytokines in the Neuropathology of Stroke and Neurotrauma

1998 • 224 citations

Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes.

1997 • 205 citations

Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-α inhibitor

1997 • 205 citations

Serial Measurement of Interleukin-6, Transforming Growth Factor-β, and S-100 Protein in Patients With Acute Stroke

1996 • 204 citations

The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases

1992 • 190 citations

Cytokines and Cell Adhesion Molecules in Cerebral Ischemia

1998 • 154 citations

Immune regulation within the central nervous system

1998 • 126 citations

Bi-Directional Induction of Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 During T Lymphoma/Endothelial Cell Contact: Implication of ICAM-1

1998 • 114 citations

A Novel Function of IL-12p40 as a Chemotactic Molecule for Macrophages

1999 • 109 citations

Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-α)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-β) treatment

2000 • 109 citations

Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts

1999 • 95 citations

Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis

1999 • 95 citations

Monocytes in multiple sclerosis: phenotype and cytokine profile

2001 • 95 citations

Glial expression of cytokines in the brains of cerebrovascular disease patients

1996 • 86 citations

Phenotype and frequency of cells secreting IL-2, IL-4, IL-6, IL-10, IFN and TNF-α in human peripheral blood

1995 • 78 citations

Organ‐specific autoantigens induce interferon‐γ and interleukin‐4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis

1994 • 77 citations

High levels of IL‐10 secreting cells are present in blood in cerebrovascular diseases

1999 • 76 citations

IL-12 in Autoimmunity

1998 • 75 citations

Cloning and characterization of human tumor cell interstitial collagenase.

1990 • 74 citations

IL-12-mediated NKRP1A up-regulation and consequent enhancement of endothelial transmigration of V delta 2+ TCR gamma delta+ T lymphocytes from healthy donors and multiple sclerosis patients.

1999 • 73 citations

The effect of interferon β-1b on lymphocyte-endothelial cell adhesion

1996 • 40 citations

Characterization of a human corneal metalloproteinase inhibitor (TIMP-1)

1993 • 32 citations

Metastasis suppressor genes.

1991 • 13 citations